A leader from healthcare commercial intelligence company Definitive Healthcare discusses the rise of precision medicine and the benefits the field can yield.
The past two years have been full of shifts and shakes in the drug development field, but the change at Outsourcing-Pharma is easy and one for the better.
Former Medable vice president Brian Ongioni has joined the trial tech provider as vice president of product, continuing a quest for patient-focused solutions.
Leaders from the biotech company share advice on how such organizations can make the most of often limited resources via smart strategy and collaboration.
The pharma manufacturing specialist is increasing capacity at its development and manufacturing labs to meet growing global demand for highly potent APIs.
Returning to an in-person format March 21-24, the industry event is bringing a range of networking, educational, and social programming to New York City.
Created via a joint effort with EY, the pharmaceutical company launched ASPIREs, a program intended to improve its clinical trial processes in numerous areas.
A leader from health tech solutions company Vytal examines supply chain challenges faced in the pharmaceutical field and shares some potential solutions.
According to the study, the country’s overreliance on pharmaceutical ingredients manufactured in overseas factories threatens national security and health.
The annual event (scheduled July 12-16 online) will feature educational sessions, presentations, and networking opportunities for drug manufacturing pros.
Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.
The two firms are joining forces to develop AI-based technology for continuous manufacturing of critical APIs necessary for producing crucial small-molecule drugs.
Bernard McGarvey, formerly of Eli Lilly, spoke with us about first principles of engineering in pharma, following his keynote ‘Engineering First Principles Applications to Pharmaceutical Manufacturing.'
Experts from Syneos Health and UDG Healthcare comment on the current state of the global pharma contract sales market – which is estimated to reach $9.48bn by 2023.
Weill Cornell Medicine has joined TriNetX’s global health research network, enabling it to collaborate with researchers and attract clinical trial opportunities.
The Good Pharma Scorecard aims to quantify what makes a “good” pharmaceutical company – as 91% of Americans think companies put money before people, says Bioethics International founder.
Regulatory changes and promising starts ups are fueling demand for outsourced services in China – and as venture capital flows into the country, the pace of innovation is expected to accelerate, says STA Pharmaceutical.
By Dennis Salotti, vice president of operations, The Avoca Group
Making the shift in the pharmaceutical industry from a risk-averse approach to overseeing clinical trials to a risk-based approach is – quite frankly – earthshaking.
This month’s roundup includes new CEOs at Bioclinica and Comprehend Systems, several hires at Parexel's consulting division, and new roles – and new offices – for two service providers.
A year after implementing its policy on the publication of clinical data, reports on 50 medicines have been published and more than 80,000 documents downloaded – outcomes achieved through industry collaboration, says EMA.
Marken has acquired Touchdown International Ltd, a privately held specialty logistics company in Taiwan – a “key market” for pharma production and clinical trials.
The MHLW has ordered Pfizer, Bayer, Daichi Sankyo and firms selling generic warfarin and azithromycin in Japan to expand their products’ adverse event warnings.
Başkent University’s hospital cluster has joined Clinerion’s Patient Recruitment System (PRS) Platform, expanding sponsor access to potential clinical trial participants.
Takeda Pharmaceutical Company Limited and Schrödinger Inc. have formed a multi-target research collaboration that leverages Schrödinger’s in silico platform-driven drug discovery capabilities.
The international contract research organization (CRO) and non-profit organization have signed a three-year “teaming agreement” to advance clinical trials for gynecologic malignancies.
Proposed amendments to the European Medicines Agency’s (EMA) access to documents policy have been criticised by medicines watchdogs, including not-for-profit Health Action International and Prescrire.
Randomized controlled trials are the fastest way to identify vaccines in an outbreak, but more collaboration is needed among international researchers – including CROs.
Diteba has developed a novel in vitro approach that allows sponsors to avoid in vivo bioequivalence studies in accordance with a recently released FDA draft guidance.
The inability to identify the best clinical trial sites is a big problem – and one of the major challenges negatively affecting drug pricing and sponsors, says CEO.
Premier Research has selected ERT’s Trial Oversight suite as its clinical trial management solution to augment sponsor collaboration and help mitigate risk.
The EMA recently updated its Good Clinical Practice (GCP) Q&A to address several contractual arrangement “pitfalls” – specifically with electronic systems vendors.
This year, DCAT Week ’17 attendees can expect several new additions to the industry event as it gathers at its new location next month in New York City.
Enteris to work on Sanofi oral type 2 diabetes candidate & metabolic peptide for Nordic Bioscience
bluebird bio Inc has hired apceth Biopharma GmbH to make its candidate ALD cell therapy Lenti-D and its thalassemia treatment LentiGlobin for the European market.
The “double edged sword” of increased regulation is a challenge, but Envigo expects outsourcing to continue as the company looks to diversity its service portfolio.
Biotrial looks to run 50 clinical trials per year at its new US-based facility as it says group activities are up – with the exception of Ph I activities in France.
Parexel has entered into a definitive agreement to acquire ExecuPharm, a global functional service provider (FSP), in a deal that it said will add scale to meet growing demand.
Charles River Laboratories has entered into a strategic partnership with the Milner Therapeutics Institute and Consortium and will provide the organization with access to its resources and services.
Medisafe is launching Medisafe for Pharma after completing several pilots over the past year and a half - one of several new applications that have emerged as the industry focuses on patient centricity.
